For the year ending 2025-12-31, BMY made $48,194M in revenue. $7,054M in net income. Net profit margin of 14.64%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total revenues | 48,194 | 48,300 | 45,006 | 46,159 |
| Cost of products sold | 13,936 | 13,968 | 10,693 | 10,137 |
| Selling, general and administrative | 7,267 | 8,414 | 7,772 | 7,814 |
| Research and development | 9,951 | 11,159 | 9,299 | 9,509 |
| Acquired iprd | 3,721 | 13,373 | 913 | 815 |
| Amortization of acquired intangible assets | 3,317 | 8,872 | 9,047 | 9,595 |
| Interest expense | - | - | 1,166 | 1,232 |
| Royalty and licensing income (note 4) | - | - | - | 1,283 |
| Interest expense | 1,891 | 1,947 | - | - |
| Royalty income - divestitures (note 4) | 1,129 | 1,104 | 862 | 832 |
| Royalty and licensing income (note 4) | 1,093 | 736 | 1,488 | - |
| Investment income | 586 | 478 | 449 | 171 |
| Divestiture losses/(gains) (note 4) | - | -15 | 0 | 211 |
| Provision for restructuring (note 6) | 563 | 635 | 365 | 75 |
| Litigation and other settlements | -434 | -84 | 390 | -178 |
| Loss on debt redemption (note 10) | -356 | 0 | 0 | -266 |
| Contingent consideration (note 9) | 351 | - | -8 | -9 |
| Intangible asset impairment | - | 47 | - | - |
| Equity investment (gains)/losses, net (note 9) | 280 | 16 | -160 | -801 |
| Integration expenses (note 6) | 147 | 284 | 242 | 440 |
| Acquisition expense | 9 | 50 | - | - |
| Other | -11 | -165 | -106 | -90 |
| Other (income)/expense, net | -674 | -893 | 1,158 | -576 |
| Total expenses | 38,866 | 56,679 | 36,566 | 38,446 |
| Earnings/(loss) before income taxes | 9,328 | -8,379 | 8,440 | 7,713 |
| Income tax provision | 2,272 | 554 | 400 | 1,368 |
| Net earnings/(loss) | 7,055 | -8,933 | 8,040 | 6,345 |
| Noncontrolling interest | 2 | 15 | 15 | 18 |
| Net earnings/(loss) attributable to bms | 7,054 | -8,948 | 8,025 | 6,327 |
| Basic (in dollars per share) | 3.47 | -4.41 | 3.88 | 2.97 |
| Diluted (in dollars per share) | 3.46 | -4.41 | 3.86 | 2.95 |
| Weighted-average common shares outstanding - basic (in shares) | 2,034,000,000 | 2,027,000,000 | 2,069,000,000 | 2,130,000,000 |
| Weighted-average common shares outstanding - diluted (in shares) | 2,039,000,000 | 2,027,000,000 | 2,078,000,000 | 2,146,000,000 |
BRISTOL MYERS SQUIBB CO (BMY)
BRISTOL MYERS SQUIBB CO (BMY)